Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/94591

Beta release

Statistics of The mortality benefit seen with the newer more potent oral P2Y(12) inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0600
2024-0700
2024-0800